Uncovering the Success of GainsWave Therapy

For those suffering from erectile dysfunction (ED), there is hope. Shockwave therapy, also known as GainsWave (GW), has been used successfully in Europe for over 15 years to treat ED. A study published in the Journal of Urology found that most patients experienced an improvement in their erectile function after just one month of shockwave therapy. The technology behind shockwave therapy has been used successfully across Europe for more than two decades.

Generally, patient satisfaction rates are reported to be positive between 75 and 80%. Interestingly, the patient satisfaction score increases slightly among those surveyed one year after treatment. This indicates that the effects are lasting, and that patients become increasingly happier over time after receiving the treatment. GainsWave is based on a series of more than 30 clinical studies showing a success rate greater than 75% in the treatment of ED.

It is also approved to treat Peyronie's disease and improve sexual performance in men without ED. The preliminary data after 1 and 3 months of follow-up are very encouraging and suggest the therapeutic success of this second-generation technology to treat ED with low-intensity linear shock waves. Shock wave therapy can also be used to successfully correct conditions such as tennis elbow, pimples, and hip bursitis. GainsWave technology has been used successfully in Europe for more than 15 years to treat ED, and there is increasing research suggesting that the treatment has the effectiveness that Dallas men expect when seeking relief from ED.